Pientzehuang Pharma
Pientzehuang Pharma, also known as Pientzehuang Pharmaceutical Co., Ltd., is a leading player in the pharmaceutical industry, headquartered in China (CN). Established in 1956, the company has made significant strides in the development of traditional Chinese medicine, particularly in the areas of anti-inflammatory and analgesic products. With a strong focus on research and innovation, Pientzehuang Pharma is renowned for its flagship product, Pientzehuang, which is celebrated for its unique formulation derived from natural ingredients. This product has positioned the company as a trusted name in both domestic and international markets. Over the years, Pientzehuang Pharma has achieved notable milestones, including various certifications and recognitions that underscore its commitment to quality and efficacy. As a pioneer in integrating traditional practices with modern science, the company continues to expand its influence across major operational regions, solidifying its market position in the global pharmaceutical landscape.
DitchCarbon Score
How does Pientzehuang Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pientzehuang Pharma's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pientzehuang Pharma's reported carbon emissions
In 2023, Pientzehuang Pharma reported total carbon emissions of approximately 9,663,230 kg CO2e, comprising 2,300,930 kg CO2e from Scope 1 emissions and 7,433,300 kg CO2e from Scope 2 emissions. This data reflects the company's ongoing commitment to monitoring and managing its carbon footprint as part of its operational practices. Despite the detailed emissions reporting, there are currently no specified reduction targets or climate pledges outlined by Pientzehuang Pharma. The absence of documented reduction initiatives suggests that the company may still be in the early stages of formalising its climate commitments within the pharmaceutical industry context. As Pientzehuang Pharma continues to grow, it will be essential for the company to establish clear climate goals and reduction strategies to align with global sustainability efforts and industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2023 | |
|---|---|
| Scope 1 | 2,300,930 |
| Scope 2 | 7,433,300 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pientzehuang Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
